FDA Shutdown Lands Hard On CFSAN-Regulated Industries
This article was originally published in The Tan Sheet
Executive Summary
The federal shutdown interrupts FDA’s increasing enforcement against firms marketing violative supplement products in addition to slowing drug application evaluations and facility inspections. FDA would retain 8,180 staff members, about 55% of its total, mostly because they could be “paid from carryover funding.”